Sanofi and GSK have signed agreements with the Government of Canada for the supply of up to 72 million doses of an adjuvanted Covid-19 vaccine, beginning in 2021.
Vifor Pharma has announced the successful sale of 100% of the share capital of OM Pharma, a Vifor Pharma Group company to Optimus Holding.
British drugmaker GlaxoSmithKline (GSK) and French pharmaceutical firm Sanofi have entered into an advanced purchase agreement with the European Commission (EC) to supply up to 300 million doses of adjuvanted Covid-19 vaccine.
Pfizer and BioNTech announced that they had concluded exploratory talks with the European Commission for a proposed supply of 200 million doses of their investigational BNT162 mRNA-based vaccine candidate against SARS-CoV-2 to European Union (EU) Member States, with an option for further 100 million doses.
Takeda Pharmaceutical announced that it has entered into an agreement to divest a portfolio of select non-core prescription pharmaceutical products sold predominantly in Europe and Canada to Cheplapharm.
Mylan has agreed to acquire the European thrombosis business from Aspen Pharmacare Holdings for €641.9m.
Takeda Pharmaceutical has agreed to divest its Japanese consumer healthcare business unit to Blackstone for $2.3bn.
AstraZeneca said that it has closed an agreement with the European Commission (EC) for the supply of up to 400 million doses of the investigational AZD1222 vaccine for the prevention of Covid-19.
Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that the U.S. government has secured 100 million doses of mRNA-1273 as part of the U.S. government’s goal of securing early access to safe and effective COVID-19 vaccines for the American people.
The high performance, inline oxygen sensors from METTLER TOLEDO stand the test of time under challenging operating conditions, whether in the biotechnology, pharmaceutical, brewing or food and beverage industry.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.